Roche Holding AG Stock price

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange 11:31:07 2024-02-28 am EST 5-day change 1st Jan Change
231 CHF -0.41% Intraday chart for Roche Holding AG -0.52% -5.52%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2024 * 59.87B 68.04B Sales 2025 * 63.57B 72.25B Capitalization 186B 211B
Net income 2024 * 13.39B 15.21B Net income 2025 * 14.82B 16.85B EV / Sales 2024 * 3.31 x
Net Debt 2024 * 12.27B 13.95B Net Debt 2025 * 6.63B 7.54B EV / Sales 2025 * 3.03 x
P/E ratio 2024 *
13.7 x
P/E ratio 2025 *
12.4 x
Employees 103,605
Yield 2024 *
4.18%
Yield 2025 *
4.34%
Free-Float 88.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.41%
1 week-0.52%
Current month-6.52%
1 month-6.65%
3 months-2.49%
6 months-10.88%
Current year-5.52%
More quotes
1 week
227.30
Extreme 227.3
234.35
1 month
222.75
Extreme 222.75
248.95
Current year
222.75
Extreme 222.75
255.90
1 year
222.75
Extreme 222.75
293.55
3 years
222.75
Extreme 222.75
404.20
5 years
222.75
Extreme 222.75
404.20
10 years
206.35
Extreme 206.35
404.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 02-12-31
Chairman 57 07-12-31
Director of Finance/CFO 57 11-03-31
Members of the board TitleAgeSince
Director/Board Member 72 15-03-02
Director/Board Member 59 -
Director/Board Member 65 95-12-31
More insiders
Date Price Change Volume
24-02-28 231 -0.41% 1,119,595
24-02-27 232 +1.22% 1,362,441
24-02-26 229.2 -1.40% 1,594,528
24-02-23 232.4 +1.55% 1,079,974
24-02-22 228.8 -0.87% 1,627,852

Delayed Quote Swiss Exchange, February 28, 2024 at 11:31 am EST

More quotes
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
231 CHF
Average target price
282.9 CHF
Spread / Average Target
+22.49%
Consensus
  1. Stock
  2. Equities
  3. Stock Roche Holding AG - Swiss Exchange
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW